Moberg Pharma AB (publ) (MOB.ST) stock: key figures, P/E, revenue and dividend
Health Care · Biotechnology · Sweden · ISIN SE0020353928
Moberg Pharma AB (publ) financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 9.81 m SEK | 13.54 m SEK |
| Gross profit | 6.32 m SEK | 7.68 m SEK |
| Operating income | -324.83 m SEK | -28.00 m SEK |
| EBIT | -320.25 m SEK | -28.00 m SEK |
| Net income | -255.11 m SEK | -27.24 m SEK |
| Diluted EPS – continuing operations | -6.74 SEK | -0.58 SEK |
Full history since 2008, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Moberg Pharma AB (publ)
Moberg Pharma AB (publ), a pharmaceutical company, develops and commercializes medical products primarily in Sweden. It offers MOB-015 for the treatment of nail fungus under the Terclara brand. The company was formerly known as Moberg Derma AB (publ) and changed its name to Moberg Pharma AB (publ) in May 2013. It has license agreement with Karo Healthcare for distribution in European market. Moberg Pharma AB (publ) was incorporated in 2006 and is based in Bromma, Sweden.
More stocks
- Forward Electronics Co., Ltd. (8085.TWO)
- BRIDGFORD FOODS CORP (BRID)
- Metro Healthcare Berhad (0329.KL)
- Aplisens SA (APN.WA)
- BASO Precision Optics Co., LTD (6517.TWO)
- YES24 Co.Ltd (053280.KQ)
- Changs Ascending Enterprise Co., Ltd. (8038.TWO)
- J&B International Inc. (4442.TWO)
- ORION ENERGY SYSTEMS, INC. (OESX)
- Ecoplastic Corporation (038110.KQ)
- Eniro Group AB (ENRO.ST)
- Lion Chemtech Co. Ltd (171120.KQ)
Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.